Nasus Pharma

NSRXNYSE Israel Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$40.461 M

$3.46 +1.92%

Close of 7 Aug 2026

Revenue

$1.24B

#1406 by revenue

Earnings

-$5.86M

Loss-making

Shares outstanding

9,015,383

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#359PDS BiotechnologyPDSB$43.4M
#360Hyperion DefiHYPD$40.9M
#361Nasus PharmaNSRX$40.5M
#362Radiopharm TheranosticsRADX$40.3M
#363CervoMedCRVO$38.8M

Where these numbers come from

Share counts and financials for Nasus Pharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.